The health assessment questionnaire 1992: status and review

scientific article published on 01 September 1992

The health assessment questionnaire 1992: status and review is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1002/ART.1790050303
P698PubMed publication ID1457486

P2093author name stringJ. F. Fries
D. R. Ramey
J. P. Raynauld
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)119-129
P577publication date1992-09-01
P1433published inArthritis Care and ResearchQ15754720
P1476titleThe health assessment questionnaire 1992: status and review
P478volume5

Reverse relations

cites work (P2860)
Q30501471A pilot study of gentle yoga for sleep disturbance in women with osteoarthritis
Q55080014A protocol for a randomised controlled trial of prefabricated versus customised foot orthoses for people with rheumatoid arthritis: the FOCOS RA trial [Foot Orthoses - Customised v Off-the-Shelf in Rheumatoid Arthritis].
Q35907809Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis
Q83380198Are fibromyalgia patients as inactive as they say they are?
Q35554601Association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis
Q35977221Brief Fear of Movement Scale for osteoarthritis
Q33578071Ceiling effects of the Health Assessment Questionnaire and its modified version in some ambulatory rheumatoid arthritis patients
Q27694496Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analy
Q37350952Comprehensibility, reliability, validity, and responsiveness of the Thai version of the Health Assessment Questionnaire in Thai patients with rheumatoid arthritis
Q57456655Contribution of the bone and cartilage/soft tissue components of the joint damage to the level of disability in rheumatoid arthritis patients: a longitudinal study
Q36983102Daily interpersonal events in pain patients: applying action theory to chronic illness
Q41581523Development and validation of a multivariate predictive model for rheumatoid arthritis mortality using a machine learning approach
Q57169507Disease activity and functional changes of RA patients receiving different DMARDs in clinical practice
Q38698132Disease-modifying anti-rheumatic drug effect of denosumab on radiographic progression in rheumatoid arthritis: a systematic review of the literature
Q37468640Evaluation of quality of life in chronic, progressing rheumatic diseases based on the example of osteoarthritis and rheumatoid arthritis.
Q48422682Factors associated with disability in a sample of adults with arthritis.
Q23917674Functional limitations and well-being in injured municipal workers: a longitudinal study.
Q90415594Genetic Association Between Growth Differentiation Factor 5 Single Nucleotide Polymorphism and Primary Knee Osteoarthritis in a Group of Egyptian Patients: A Pilot Study
Q93050688Hand exercise for women with rheumatoid arthritis and decreased hand function: an exploratory randomized controlled trial
Q35550798Health Assessment Questionnaire modifications: is standardisation needed?
Q26738901Health-related quality of life in mucopolysaccharidosis: looking beyond biomedical issues
Q59880008High levels of Lymphotoxin-Beta (LT-Beta) gene expression in rheumatoid arthritis synovium: clinical and cytokine correlations
Q35840735Improved responsiveness and reduced sample size requirements of PROMIS physical function scales with item response theory
Q30847229Improving physical activity in arthritis clinical trial (IMPAACT): study design, rationale, recruitment, and baseline data
Q51539744Inadequate Therapy Behavior Is Associated to Disease Flares in Patients With Rheumatoid Arthritis Who Have Achieved Remission With Disease-Modifying Antirheumatic Drugs
Q37245192Infliximab improves vascular stiffness in patients with rheumatoid arthritis
Q33929250Juvenile rheumatoid arthritis--assessment
Q36806851Long-term galsulfase enzyme replacement therapy in Taiwanese mucopolysaccharidosis VI patients: A case series
Q35551088Measuring the meaning of disability in rheumatoid arthritis: the Personal Impact Health Assessment Questionnaire (PI HAQ)
Q37207129Medication persistence over 2 years of follow-up in a cohort of early rheumatoid arthritis patients: associated factors and relationship with disease activity and with disability
Q33872713Modeling the temporal complexities of symptoms
Q46456972Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide for rheumatoid arthritis in Germany: II. The contribution of leflunomide to efficiency
Q41912381Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide in rheumatoid arthritis in Germany: I. Selected DMARDs and patient-related costs
Q39168790Modelling outcomes of complex treatment strategies following a clinical guideline for treatment decisions in patients with rheumatoid arthritis.
Q34449612Motivations for inadequate persistence with disease modifying anti-rheumatic drugs in early rheumatoid arthritis: the patient's perspective
Q44290205NADPH oxidase priming and p47phox phosphorylation in neutrophils from synovial fluid of patients with rheumatoid arthritis and spondylarthropathy
Q52902721Natural history and galsulfase treatment in mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy syndrome)--10-year follow-up of patients who previously participated in an MPS VI Survey Study.
Q36952375Natural history of alpha mannosidosis a longitudinal study
Q35124663New potential determinants of disability in aged persons with myocardial infarction: results from the KORINNA-study
Q82732857Osteoporosis in psoriatic arthritis: is there any?
Q48372838Outcomes after rheumatoid arthritis patients complete their participation in a long-term observational study with tofacitinib combined with methotrexate: practical and ethical implications in vulnerable populations after tofacitinib discontinuation.
Q26752745Pain Assessment--Can it be Done with a Computerised System? A Systematic Review and Meta-Analysis
Q41595008Patient's perspective of sustained remission in rheumatoid arthritis
Q35780350Patient-reported outcomes and their role in the assessment of rheumatoid arthritis
Q53628346Physical activity, the compression of morbidity, and the health of the elderly.
Q36737894Physical function assessment tools in pediatric rheumatology
Q35185494Prevalence, incidence and characteristics of the metabolic syndrome (MetS) in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugs: the complex relationship between MetS and
Q37184160Psychometric evaluation of a Moroccan version of health assessment questionnaire for use in Moroccan patients with rheumatoid arthritis
Q34506399Rasch Analysis of the Fullerton Advanced Balance (FAB) Scale
Q40322064Reducing need and demand for medical services in high-risk persons. A health education approach
Q35496180Self-reported disability in adults with severe obesity.
Q61989379Sexual Function in Females With Rheumatoid Arthritis: Relationship With Physical and Psychosocial States
Q35553490Short course prednisolone for adhesive capsulitis (frozen shoulder or stiff painful shoulder): a randomised, double blind, placebo controlled trial
Q37678247Social support: a key variable for health promotion and chronic disease management in Hispanic patients with rheumatic diseases
Q34389411Socioeconomic disparities in the health of african americans with rheumatoid arthritis from the southeastern United States.
Q52598701Supine behaviour predicts the time to death in male Mediterranean fruitflies (Ceratitis capitata).
Q91724018Systemic Th17 response in the presence of periodontal inflammation
Q38086137Targeting interleukin-6 in rheumatoid arthritis
Q37374964The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial
Q24806173The Stanford Health Assessment Questionnaire: dimensions and practical applications
Q80643961The adaptation, reliability and validity testing of the Estonian version of the Health Assessment Questionnaire's Disability Index
Q30422274The effect of acceptance training on psychological and physical health outcomes in elders with chronic conditions
Q51187842The efficacy of peloid therapy in management of hand osteoarthritis: a pilot study.
Q74263080The impact of disability and disease duration on social support of women with rheumatoid arthritis
Q30479153Theoretical framework and methodological development of common subjective health outcome measures in osteoarthritis: a critical review
Q36614417Toward Ensuring Health Equity: Readability and Cultural Equivalence of OMERACT Patient-reported Outcome Measures
Q37607063Treatment of rheumatoid arthritis: state of the art 2009.
Q35550617Validating English- and Spanish-language patient-reported outcome measures in underserved patients with rheumatic disease
Q35549789Values for function in rheumatoid arthritis: patients, professionals, and public.
Q35842618Window of opportunity to achieve major outcomes in early rheumatoid arthritis patients: how persistence with therapy matters
Q81159525[Patient-centered assessment of functional health in systemic sclerosis -- where are we now?]

Search more.